Home | Business News | Browse by Publication | P | Pharma Marketletter

Dr Reddy's files for US generic levetiracetam.

Publication: Pharma Marketletter
Publication Date: 29-MAR-04
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Indian firm Dr Reddy's Laboratories has filed an Abbreviated New Drug Application with the US Food and Drug Administration for levetiracetam, the generic form of UCB Pharma's branded epilepsy drug Keppra, in tablets of 250mg, 500mg and 750mg, with a Paragraph IV certification on the two Orange Book patents...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
US slammed over HIV/ AIDS drugs meeting.(Brief Article), March 29, 2004
Richter refuses to sign for NHF payback.(Richter Gedeon)(National Heal..., March 29, 2004
AstraZeneca's Faslodex meets unmet need in breast cancer., March 29, 2004
Roche Bondronat: clarifications.(Correction Notice), March 29, 2004
Pharmacopeia expands Celgene research alliance.(Brief Article), March 29, 2004

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.